CommScope (NASDAQ:COMM – Get Free Report) will be releasing its earnings data before the market opens on Thursday, November 7th. Analysts expect CommScope to post earnings of $0.33 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.
CommScope (NASDAQ:COMM – Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The communications equipment provider reported $0.34 EPS for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.01). CommScope had a negative net margin of 31.24% and a negative return on equity of 3.08%. The business had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same quarter last year, the firm earned $0.14 earnings per share. The firm’s quarterly revenue was down 12.7% compared to the same quarter last year. On average, analysts expect CommScope to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
CommScope Stock Performance
CommScope stock opened at $6.42 on Tuesday. The stock has a market capitalization of $1.39 billion, a P/E ratio of -0.79, a P/E/G ratio of 0.30 and a beta of 2.09. The company’s fifty day moving average price is $5.66 and its 200 day moving average price is $3.10. CommScope has a 1 year low of $0.86 and a 1 year high of $7.07.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on CommScope
CommScope Company Profile
CommScope Holding Company, Inc provides infrastructure solutions for communications, data center, and entertainment networks worldwide. The company operates through Connectivity and Cable Solutions (CCS); Outdoor Wireless Networks (OWN); Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS) segments.
Featured Articles
- Five stocks we like better than CommScope
- ETF Screener: Uses and Step-by-Step Guide
- Intel: Is Now the Time to Be Brave?Â
- Energy and Oil Stocks Explained
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- The Risks of Owning Bonds
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for CommScope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CommScope and related companies with MarketBeat.com's FREE daily email newsletter.